Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04829708
Status:
RECRUITING
Last Update Posted:
2021-04-29
First Post:
2021-03-27
Brief Title:
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Shandong Cancer Hospital and Institute
Study Overview
Official Title:
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy a Multicenter Randomized Controlled Phase III Clinical Trial
Status:
RECRUITING
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective openmulticenter randomized controlled phase III clinical trial In patients with LS-SCLC who achieve remission after first-line chemoradiotherapy the efficacy and safety of PCI or MRI surveillance is evaluated and analyzed PCI is performed in hopes of preventing spread of cancer into the brain The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients lifespan MRI surveillance alone delaying radiation until the actual brain metastasis may be not inferior to PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None